Q1 2022 Holdings
Filed 2022-05-16 | 81 holdings | $487.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cincor Pharma Inc | COM | 17240Y109 | $30.4K | 1,735,293 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $31.6K | 7,411,503 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $32.2K | 1,744,012 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $40.3K | 2,664,521 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $41.6K | 2,394,714 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $41.7K | 8,929,690 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $44.5K | 1,647,400 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $45.1K | 1,400,201 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $46.2K | 1,810,549 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $48.9K | 1,597,966 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $49.7K | 12,025,570 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $51.5K | 3,203,783 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $64.9K | 1,046,283 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $83.4K | 5,858,776 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $98.8K | 3,530,543 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $99.1K | 4,183,219 | 0.0% |
| Merus N V | COM | N5749R100 | $109.3K | 4,135,071 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $135.6K | 4,530,605 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $151.8K | 3,586,658 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $169.6K | 9,275,158 | 0.0% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $1.1M | 289,663 | 0.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.2M | 1,370,947 | 0.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $11.5M | 1,532,282 | 2.4% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $14.9M | 879,085 | 3.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $15.5M | 5,803,700 | 3.2% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $24.4M | 1,616,665 | 5.0% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $56.2M | 5,369,459 | 11.5% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $65.9M | 3,003,879 | 13.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $68.6M | 3,976,543 | 14.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $99.7M | 316,204 | 20.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $125.0M | 3,960,948 | 25.7% |